JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ABTX
3051
DELISTED
Allegiance Bancshares
ABTX
| $1.45M | ﹤0.01% |
37,850
-3,135
| -8% | -$120K |
2016 Q1
5 quarters
|
|
3052
Par Pacific Holdings
PARR
$4.34B
| $1.45M | ﹤0.01% |
+80,288
| New | +$1.35M |
2017 Q2
0 quarters
|
|
|
NXGN
3053
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.45M | ﹤0.01% |
84,173
-42,396
| -33% | -$644K |
2016 Q4
2 quarters
|
|
3054
Global X MLP ETF
MLPA
$2.3B
| $1.43M | ﹤0.01% |
21,892
+113
| +0.5% | +$7.55K |
2015 Q4
6 quarters
|
|
3055
Invesco BuyBack Achievers ETF
PKW
$1.7B
| $1.43M | ﹤0.01% |
26,687
-425
| -2% | -$22.3K |
2013 Q2
16 quarters
|
|
3056
CTS Corp
CTS
$1.75B
| $1.43M | ﹤0.01% |
66,290
-28,868
| -30% | -$611K |
2016 Q2
4 quarters
|
|
3057
PUT
lululemon athletica
LULU
$10.4B
| $1.43M | ﹤0.01% |
+23,900
| New | +$1.24M |
2017 Q2
0 quarters
|
|
3058
iShares US Healthcare Providers ETF
IHF
$1.38B
| $1.42M | ﹤0.01% |
47,940
+10,745
| +29% | +$302K |
2013 Q2
16 quarters
|
|
|
TARO
3059
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $1.42M | ﹤0.01% |
12,661
-996
| -7% | -$113K |
2015 Q4
6 quarters
|
|
3060
AnaptysBio
ANAB
$1.45B
| $1.41M | ﹤0.01% |
59,100
-79,638
| -57% | -$2M |
2017 Q1
1 quarter
|
|
|
PRFT
3061
DELISTED
Perficient Inc
PRFT
| $1.41M | ﹤0.01% |
75,856
-32,118
| -30% | -$556K |
2016 Q1
5 quarters
|
|
3062
Digi International
DGII
$2.83B
| $1.41M | ﹤0.01% |
139,017
-5,746
| -4% | -$61K |
2015 Q1
9 quarters
|
|
|
MDCO
3063
PUT
DELISTED
Medicines Co
MDCO
| $1.41M | ﹤0.01% |
37,100
+29,000
| +358% | +$1.29M |
2016 Q1
5 quarters
|
|
3064
Energy Recovery
ERII
$361M
| $1.41M | ﹤0.01% |
169,651
-48,125
| -22% | -$385K |
2013 Q2
16 quarters
|
|
|
ORIT
3065
DELISTED
Oritani Financial Corp. New
ORIT
| $1.4M | ﹤0.01% |
82,323
-119,441
| -59% | -$2.02M |
2015 Q3
7 quarters
|
|
3066
CALL
Weibo
WB
$1.59B
| $1.4M | ﹤0.01% |
+21,093
| New | +$1.37M |
2017 Q2
0 quarters
|
|
3067
iShares Short-Term National Muni Bond ETF
SUB
$11.9B
| $1.4M | ﹤0.01% |
13,204
-1,656
| -11% | -$175K |
2015 Q1
9 quarters
|
|
|
VRN
3068
DELISTED
Veren
VRN
| $1.4M | ﹤0.01% |
182,315
-277,942
| -60% | -$2.6M |
2014 Q1
13 quarters
|
|
|
ARAV
3069
CALL
DELISTED
Aravive, Inc. Common Stock
ARAV
| $1.4M | ﹤0.01% |
13,333
| – | – |
2017 Q1
1 quarter
|
|
|
HRG
3070
DELISTED
HRG Group, Inc.
HRG
| $1.39M | ﹤0.01% |
78,627
-89,551
| -53% | -$1.68M |
2015 Q2
8 quarters
|
|
|
KATE
3071
PUT
DELISTED
Kate Spade & Company
KATE
| $1.39M | ﹤0.01% |
+75,300
| New | +$1.39M |
2017 Q2
0 quarters
|
|
3072
Super Micro Computer
SMCI
$28.6B
| $1.39M | ﹤0.01% |
564,210
-346,510
| -38% | -$847K |
2016 Q4
2 quarters
|
|
|
RBL
3073
DELISTED
SPDR S&P Russia ETF
RBL
| $1.39M | ﹤0.01% |
76,245
+959
| +1% | +$18.3K |
2016 Q3
3 quarters
|
|
|
CKH
3074
DELISTED
Seacor Holdings Inc.
CKH
| $1.39M | ﹤0.01% |
41,785
-228,954
| -85% | -$12.1M |
2013 Q2
16 quarters
|
|
|
TVRD
3075
PUT
Tvardi Therapeutics
TVRD
$15.1M
| $1.39M | ﹤0.01% |
+2,500
| New | +$1.59M |
2017 Q2
0 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.